CLINICAL_TRIALS
trial_result
· 2022-12-28
Clinical Trial Update: Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI [Phase 3]
Summary
Phase 3 multicenter single-arm trial evaluating denosumab in children with osteogenesis imperfecta; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: TERMINATED | Results posted: 2022-12-28